Evaluating Bispecific Antibody Potency Using T Cell-Dependent Cellular Cytotoxicity Assays
TDCC Assay: Revolutionizing Tumor Cell Cytotoxicity Assessment Discover how the TDCC (Target-Dependent Cell Cytotoxicity) assay offers a cutting-edge approach to evaluating antibody efficacy by accurately measuring immune-mediated tumor cell killing. This white paper explores the assay’s methodology, applications, and advantages in immuno-oncology research and therapeutic development. Explore the Full Whitepaper ! Email Address * Name …